---

Transient Ischemic Attack (TIA) - Complete MBBS Intern Guide

---

1. Definition (The Modern Tissue-Based Definition)

"A TIA is defined as transient neurologic dysfunction caused by focal ischemia of brain tissue, spinal cord, or retina without acute infarction."

• Frameworks for Internal Medicine

"Patients with symptoms less than 24 hours can have representative ischemic lesions on diffusion-weighted or perfusion-weighted MRI, so TIA has moved from time-based to tissue-based definition."

• Rosen's Emergency Medicine

---

2. Pathophysiology & Mechanisms

"It has been realized that many TIAs previously attributed to atherothrombosis are truly embolic strokes that leave a trace of infarction but have resolved clinically."

• Adams & Victor's Principles of Neurology

---

3. Clinical Features

Anterior Circulation (Carotid territory) TIA:

• Hemiparesis / hemiplegia (contralateral)
• Hemisensory loss (contralateral face, arm, leg)
• Aphasia (if dominant hemisphere)
• Amaurosis fugax - transient monocular blindness ("curtain coming down"), from ophthalmic artery (branch of ICA)

Posterior Circulation (Vertebrobasilar) TIA:

• Diplopia, dysarthria, dysphagia
• Vertigo + ataxia (cerebellar)
• Crossed deficits (ipsilateral cranial nerve + contralateral limb weakness)
• Drop attacks (sudden loss of postural tone without LOC)
• Bilateral visual field defects

"TIAs may present as transient spells of hemiparesis, aphasia, numbness or tingling on one side, dysarthria, diplopia, ataxia, obscuration of a visual field, or combinations thereof that replicate the stroke syndromes. Even limb shaking can represent a TIA."

• Adams & Victor's Principles of Neurology

---

4. Risk of Subsequent Stroke (Why TIA is a Neurological Emergency)

• Up to 10% stroke risk within 2 days
• Up to 15% stroke risk at 90 days (Frameworks for Internal Medicine)
• ~6% of strokes after TIA occur within one month of the first attack
• ~6% more in the following year (Adams & Victor)

---

5. Risk Stratification - The ABCD² Score

• Score 0: 0% | Score 4: 8% | Score 5: 12% | Score 6: 17% | Score 7: 22%

• 0-3: Low risk (1% stroke in 48h)
• 4-5: Moderate risk (4.1% in 48h)
• ≥6: High risk (8% in 48h)

Note: More recent studies have found the ABCD² score alone is insufficient - it should be combined with DWI-MRI/MRA (ABCD²-I or ABCD³-I scoring) for better prediction. - Rosen's

---

6. Differential Diagnosis

---

7. Investigations

Immediate (Emergency) Workup:

1. Non-contrast CT brain - Rule out haemorrhage (hemorrhagic stroke contraindication to antiplatelets)
2. MRI brain with DWI - Detects early infarction (DWI positive = stroke, not TIA); gold standard
3. CT angiography / MR angiography - Carotid and intracranial vessels
4. ECG - Screen for atrial fibrillation
5. Blood glucose - Rule out hypoglycemia
6. CBC, coagulation, lipids, renal function
7. Echocardiogram - Screen for cardiac source (if cardioembolic mechanism suspected)
8. Carotid Doppler - Ipsilateral carotid stenosis assessment

---

8. Management

A. Antiplatelet Therapy (Cornerstone of Treatment)

"The combination of aspirin and clopidogrel was found to prevent stroke following TIA better than aspirin alone in a large Chinese randomized trial [CHANCE] and the NIH-sponsored POINT trial."

• Harrison's 22E

• DAPT started within 24 hours and continued for 21 days is the current standard
• After 21 days, switch to single antiplatelet (aspirin or clopidogrel alone)
• The benefit of DAPT is confined to the first 21 days (pooled POINT + CHANCE analysis)

"Failure to respond to clopidogrel is linked to carriage of a common CYP2C19 polymorphism...this mutation is common, particularly in Asians."

• Harrison's 22E

B. Anticoagulation

• Indicated when the mechanism is cardioembolism (e.g., atrial fibrillation)
• Direct oral anticoagulants (DOACs) are preferred over warfarin for AF
• Thrombolysis (tPA) is contraindicated if symptoms are improving (a defining feature of TIA)

C. Statin Therapy

• Atorvastatin 80 mg/day (SPARCL trial): significant reduction in secondary stroke and TIA
• Target LDL <70 mg/dL for secondary prevention
• All patients with prior ischemic TIA should receive a statin

D. Blood Pressure Control

• Target <130/80 mmHg (all hypertension should be treated)
• SPRINT trial: SBP <120 mmHg reduced stroke + MI by 43%
• Preferred agents: thiazide diuretics and ACE inhibitors (Harrison's 22E)

---

9. Carotid Endarterectomy (CEA) - Surgical Prevention

• Symptomatic hemispheric ischemia
• High-grade ipsilateral ICA stenosis
• Institutional perioperative morbidity/mortality ≤6%
• Most beneficial when performed within 2 weeks of symptom onset
• Greater benefit in patients >75 years and in men

---

10. Secondary Prevention Summary

---

11. Memory Aids for Internship

• Age ≥60 (1 pt)
• Blood pressure ≥140/90 (1 pt)
• Clinical features: weakness (2 pts), speech only (1 pt)
• Duration: >60 min (2 pts), 10-59 min (1 pt)
• Diabetes (1 pt)

---

Key References

• Harrison's Principles of Internal Medicine 22E (2025), Chapters 438-439
• Adams & Victor's Principles of Neurology 12E, Chapter 33
• Rosen's Emergency Medicine 10E, Chapter 87
• Frameworks for Internal Medicine, Chapter 43

---

Yellow Phosphorus Ingestion: Prognosis

Short Answer: BAD - Very Poor Prognosis

---

Why It's So Dangerous - Mechanism of Toxicity

"Phosphorus is a protoplasmic poison. It affects cellular oxidation. Its effect on cellular metabolism is comparable to ischaemia... This is known as necrobiosis, which is classically manifested in the liver."

• Parikh's Textbook of Medical Jurisprudence, Forensic Medicine and Toxicology

1. Local irritant action on the GI tract
2. Absorbed phosphorus stays in blood in elemental form for 1-2 days
3. Gets oxidised to hypophosphorous and phosphorous acids - acting as a hepatotoxic, protoplasmic poison
4. Causes widespread fatty infiltration and degeneration, especially in liver and cerebral cortex
5. Disturbs carbohydrate, fat, and protein metabolism - fat deposits in liver at the cost of glycogen (necrobiosis)
6. Leads to acute yellow atrophy of the liver - the pathognomonic end-stage finding

---

Fatal Dose and Fatal Period

---

The Triphasic Clinical Course (Key Feature for Exams)

Stage 1 - GI Irritation (within 2-6 hours, lasts 1-2 days)

• Garlic taste in mouth, garlic odour in breath
• Luminous vomitus and phosphorescent faeces (glows in the dark) - pathognomonic
• Burning pain throat to stomach
• Profuse vomiting (bile-stained, blood-tinged)
• Diarrhoea, intense thirst
• Cardiac and respiratory depression, cold clammy skin
• Patient may die at this stage from cardiovascular collapse

Stage 2 - Apparent Recovery / "Honeymoon Phase" (2-4 days)

• Symptoms reduce in intensity, vitals seem to improve
• Patient and doctor may feel reassured
• This is deceptive - phosphorus is being absorbed and oxidised, silently damaging the liver

Stage 3 - Hepatorenal Failure (starts around Day 4-7)

• Vomiting and diarrhoea return more severely
• Jaundice sets in and deepens rapidly
• Liver enlarged, soft, tender → later shrinks (acute yellow atrophy = necrosis)
• Haemorrhagic manifestations: epistaxis, haematemesis, haematuria, melaena, petechiae - from coagulopathy (hypoprothrobinaemia)
• Renal failure: oliguria → anuria; urine contains blood, albumin, bile, amino acids (leucine, tyrosine, cysteine)
• CNS: headache, tinnitus, vertigo, insomnia, delirium, priapism (frequent), cramps, paralysis
• Hypoglycaemia, weak irregular pulse, falling BP, pulmonary oedema, cyanosis
• Death from hepatic and renal insufficiency

"The clinical picture is suggestive of acute yellow atrophy of the liver."

• Parikh's Textbook

---

Prognostic Markers (Recent Evidence)

• Overall mortality: 36.5%
• Mean survival among those who died: 5.26 days after ingestion
• Symptoms (GI + neurological) typically appear ~48 hours post ingestion

"As progression to death occurs within a week of yellow phosphorus ingestion in most cases, determining prognosis as early as possible enables swift referral to a liver transplant centre."

• Ramkumar et al., Clin Toxicol 2024 [PMID: 39132751]

---

Treatment (and Why Prognosis Remains Poor Despite Treatment)

---

Summary Table

---

---

Vitamin B12 (Cobalamin) Deficiency - Complete Guide for MBBS Intern

---

1. Biochemistry Basics

• The folate trap: B12 deficiency "traps" folate as 5-methylTHF, making it unavailable for DNA synthesis → megaloblastic changes
• MMA accumulation damages myelin directly → explains the neurological syndrome independent of anemia

---

2. Absorption of Vitamin B12 (Must Know for Exams)

1. Mouth/Stomach: Dietary B12 (bound to food protein) is freed by pepsin; binds to salivary haptocorrin (R-protein)
2. Stomach: Gastric parietal cells secrete Intrinsic Factor (IF) simultaneously
3. Duodenum: Pancreatic proteases cleave the haptocorrin-B12 complex; free B12 binds to IF → IF-B12 complex
4. Terminal ileum: IF-B12 complex binds to cubilin receptor on ileal enterocytes and is endocytosed
5. Systemic: B12 binds to Transcobalamin II and is transported to liver and bone marrow

---

3. Causes / Etiology

A. Decreased Intrinsic Factor (Most Common in Adults)

B. Food-Cobalamin Malabsorption

• Type B atrophic gastritis (H. pylori, age-related achlorhydria)
• PPI or H2-blocker use (reduce acid needed to release B12 from food)
• Metformin - reduces absorption via unknown mechanism (very common, clinically important!)

C. Ileal Disorders (Loss of Absorption Site)

• Terminal ileal resection or Crohn's disease
• Imerslund-Gräsbeck syndrome (congenital cubilin receptor defect)
• Ileal conduit surgery

D. Usurpation / Competition in Gut

• Bacterial overgrowth (blind loop syndrome)
• Fish tapeworm - Diphyllobothrium latum (competes for B12)
• Tropical sprue

E. Nutritional Deficiency

• Strict vegans (no animal products)
• Breast-fed infant of a B12-deficient mother
• Elderly with poor intake

F. Drug-Induced

• Nitrous oxide (N₂O) - irreversibly oxidises cobalamin; causes acute SCD especially in marginally deficient patients ("anesthesia paresthetica" in operating room staff and whippet abusers)
• Metformin, PPIs, H2 blockers

"Vitamin B12 deficiency is virtually never caused by inadequate intake except in vegetarians who scrupulously avoid milk and eggs."

• Robbins Basic Pathology

---

4. Clinical Features

A. Haematological (Megaloblastic Anaemia)

• Insidious onset: pallor, easy fatigability, dyspnoea on exertion
• Severe anaemia → congestive cardiac failure
• Mild jaundice (from ineffective erythropoiesis - intramedullary haemolysis)
• Glossitis - beefy red, smooth, sore tongue (Hunter's glossitis)
• Anorexia, weight loss

B. Neurological - Subacute Combined Degeneration (SCD) of Spinal Cord

"The spinal cord, brain, optic nerves, and peripheral nerves are all affected by vitamin B12 deficiency, giving rise to a classic neurologic syndrome in which the spinal cord is usually affected first and often exclusively."

• Adams & Victor's Principles of Neurology

• Posterior columns (dorsal columns) - first and most severely affected
• Lateral corticospinal tracts - hence "combined"

1. Paresthesias - symmetrical tingling, "pins and needles" in hands and feet (often hands first)
2. Sensory ataxia - unsteady gait, worsens in the dark; loss of vibration and position sense
3. Motor signs - spasticity, hyperreflexia, Babinski positive (but early on reflexes may be absent due to concurrent neuropathy)
4. Cognitive/psychiatric - irritability, apathy, dementia, depression, psychosis ("megaloblastic madness")
5. Optic neuropathy - centrocecal scotomas, optic atrophy (less common)
6. Autonomic dysfunction - urinary incontinence, impotence

"Importantly, folate administration does not prevent and may worsen neurologic symptoms that are specific to vitamin B12 deficiency."

• Robbins Basic Pathology

C. Other Features

• Increased risk of gastric carcinoma in pernicious anemia patients
• Thrombocytopenia, leukopenia (pancytopenia in severe cases)
• Hyperhomocysteinemia → increased thrombotic and cardiovascular risk

---

5. Investigations

Blood Count and Film

Serum Levels

Key distinction: MMA is elevated in B12 deficiency but NOT in folate deficiency. Homocysteine is elevated in both.

For Pernicious Anemia Specifically

• Anti-intrinsic factor antibodies (highly specific, ~50% sensitive)
• Anti-parietal cell antibodies (sensitive ~90%, but less specific)
• Schilling test (now rarely done): shows malabsorption corrected by oral IF administration

Imaging (Neurology)

• MRI spine: T2 hyperintensity in posterior columns ± lateral columns of cervical and upper thoracic cord - pathognomonic when present

---

6. B12 vs Folate Deficiency - Distinguishing Features

---

7. Treatment

Parenteral B12 (First-line for Pernicious Anemia and SCD)

"The diagnosis of pernicious anemia demands the administration of vitamin B12 and the continuation of treatment for the rest of the patient's life."

• Adams & Victor's Principles of Neurology

• Cyanocobalamin or hydroxocobalamin 1000 μg IM daily for 1 week
• Then 1000 μg IM weekly for 1 month
• Then 1000 μg IM monthly for life (in pernicious anemia)

Oral High-Dose B12 (Alternative for dietary/mild cases)

• 500-1000 μg oral daily can work even in malabsorption (via passive diffusion ~1% absorption without IF)
• Effective for vegans, elderly with dietary deficiency, maintenance therapy
• Caution: Reserve parenteral therapy for manifest neurological disease (SCD)

Monitoring Response

• Reticulocyte count rises within 2-3 days of starting B12 - first sign of response
• Hb begins rising in ~1 week; normalises over 6-8 weeks
• Neurological recovery: greatest in patients with symptoms <3 months; if treated early (within weeks), recovery is usually complete

"All neurologic symptoms and signs may improve, mostly during the first 3 to 6 months of therapy... In practically all instances there is some degree of improvement, although in cases of longest duration, the best that can be accomplished is an arrest of progression."

• Adams & Victor

Important Cautions in Treatment

• Never give folate alone in unconfirmed megaloblastic anaemia - it will correct the anaemia but allow neurological disease to progress untreated
• Give both B12 and folate if unsure, until results confirm which is deficient
• In severe anaemia, if blood transfusion is needed, give slowly to avoid precipitating heart failure

---

8. Pernicious Anemia - Special Note

• Type A autoimmune (fundal) atrophic gastritis
• Autoantibodies: anti-parietal cell antibodies AND anti-intrinsic factor antibodies
• Associated with other autoimmune diseases: Hashimoto's thyroiditis, type 1 DM, Addison's disease, vitiligo
• Increased risk of gastric adenocarcinoma and gastric carcinoid tumours - requires endoscopic surveillance
• Predominantly affects females, middle age to elderly
• Can be congenital (rare, presents in infancy)

---

9. Memorable Summary

B12 Deficiency = 3 A's (from MBBS exam perspective):
  1. Anaemia (megaloblastic)
  2. Axonal/cord disease (SCD = posterior + lateral columns)
  3. Autoimmune (pernicious anemia as the main cause)

Lab clue:  ↑MMA + ↑homocysteine = B12 deficiency
           Normal MMA + ↑homocysteine = folate deficiency

Treatment trap: NEVER correct anaemia with folate alone
               - masks B12 deficiency while neurology worsens

---

---

Graft-versus-Host Disease (GVHD) - Complete Guide for Medical Intern

---

The Core Concept - Think of It This Way

---

1. Definition

"GVHD occurs when immunologically competent cells or their precursors are transplanted into immunologically depleted recipients, and the transferred cells recognize alloantigens in the host and attack host tissues."

• Robbins Basic Pathology

---

2. When Does GVHD Occur?

1. The transplanted cells must be immunologically competent (contain functioning T cells)
2. The recipient must express tissue antigens not present in the donor (HLA or minor histocompatibility antigen mismatch)
3. The recipient must be unable to reject the transplanted cells (because they've been deliberately immunosuppressed and irradiated)

• Solid organ transplants containing lymphoid tissue (small bowel, liver, lung)
• Blood transfusion of non-irradiated blood to an immunocompromised patient
• Intrauterine or neonatal transfusion
• Even autologous HSCT can cause a mild, self-limited GVHD (loss of self-tolerance from conditioning)

---

3. Pathophysiology - Step by Step

Step 1: The Conditioning Regimen Primes the Battlefield

• Destroy their diseased bone marrow
• Suppress immunity enough to accept the donor graft

Step 2: Donor T Cells Recognise Host as Foreign

• See host minor histocompatibility antigens presented by host APCs
• Become activated (via TCR + MHC interaction)
• Clonally expand

"In most cases, the reaction is directed against minor histocompatibility antigens of the host because bone marrow transplantation is not usually performed when there are differences in MHC alleles."

• Cellular & Molecular Immunology

Step 3: Effector Attack on Host Tissues

• CD8+ CTLs directly kill host epithelial cells
• NK cells attack dying host epithelium (seen on histology)
• Cytokines (TNF-α, IFN-γ) amplify tissue destruction
• Result: epithelial cell apoptosis and necrosis in the three main target organs: skin, liver, gut

---

4. Classification: Acute vs Chronic GVHD

Acute GVHD

"Grade IV GVHD is characterised by full-thickness slough and may resemble toxic epidermal necrolysis, and it may be impossible to distinguish the two clinically or histologically."

• Andrews' Diseases of the Skin

---

Chronic GVHD

• Skin: Dermal fibrosis resembling systemic sclerosis (scleroderma); lichenoid changes, dry skin, hair loss, nail dystrophy
• Liver: Biliary fibrosis, cholestasis
• Lungs: Bronchiolitis obliterans (obliteration of small airways) - a feared, often irreversible complication
• Eyes: Dry eyes (sicca syndrome)
• Mouth: Dry mouth, lichen planus-like lesions
• Joints: Contractures from fibrosis
• Mimics: Can look like Sjögren's, scleroderma, lichen planus, polymyositis, or other autoimmune diseases

"Patients develop skin lesions with dermal fibrosis resembling those of systemic sclerosis and manifestations mimicking other autoimmune disorders."

• Robbins Basic Pathology

---

5. The GVHD-GVT Paradox (Extremely Important Concept)

• If you deplete T cells from the graft → GVHD is eliminated but GVT effect is lost → cancer relapses
• Also, T-cell depleted grafts engraft poorly and increase risk of EBV-related B-cell lymphoma

"Depletion of donor T cells before transplantation virtually eliminates the disease. This approach, however, is a mixed blessing: GVHD is reduced, but the recurrence of tumor in patients with leukemia, as well as the incidence of graft failures and EBV-related B-cell lymphoma, increase."

• Robbins Basic Pathology

---

6. Prevention

---

7. Treatment

• High-dose corticosteroids (prednisolone 1-2 mg/kg/day) - mainstay of treatment
• Steroid-refractory acute GVHD carries a very poor prognosis; options include ruxolitinib (JAK1/2 inhibitor), anti-thymocyte globulin, basiliximab

• Corticosteroids + calcineurin inhibitors (cyclosporine/tacrolimus)
• Ibrutinib (BTK inhibitor) - FDA approved for steroid-refractory chronic GVHD
• Ruxolitinib - approved for both steroid-refractory acute and chronic GVHD
• Phototherapy: Narrow-band UVB, PUVA, UVA1 - used as second-line agents, especially for sclerodermoid skin disease

---

8. Summary Table - Acute vs Chronic GVHD

---

9. Intern-Level Memory Hook

GVHD = "The Gift That Fights Back"

Who gets it? → Allogeneic HSCT recipients
Who causes it? → Donor T cells
Who they attack? → Skin, Liver, Gut (the SLiG organs)
Acute = KILL (apoptosis, necrosis, bloody diarrhoea)
Chronic = SCAR (fibrosis, looks like autoimmune disease)
Key paradox: Kill T cells → no GVHD but cancer comes back (lose GVT effect)
Prevention: HLA match + cyclosporine/tacrolimus + methotrexate
Treatment: Steroids first; ruxolitinib/ibrutinib if refractory

---

---

Anatomy of the Liver and Gallbladder - Complete Guide for Medical Intern

---

PART 1: THE LIVER

1. Gross Features - The Basics

• Largest solid organ and largest gland in the body
• Weighs 1400-1600 g in the healthy adult (Robbins)
• Dimensions roughly 15 cm x 20 cm x 10 cm

• Right hypochondrium and epigastric region
• Protected under the right costal margin
• The upper border reaches up to the 4th intercostal space (right nipple level)
• Lower border follows the right costal margin, crosses the epigastrium to the left

• Covered by Glisson's capsule (fibrous capsule) which sends septa into the parenchyma
• Mostly covered by peritoneum except the bare area - a triangular area on the posterior surface that is directly in contact with the diaphragm (no peritoneum)

---

2. Surfaces and Impressions

• Convex, faces upward and anteriorly
• In contact with the diaphragm
• Divided into right and left lobes by the falciform ligament

• Left limb: Fissure for ligamentum teres (round ligament) anteriorly + fissure for ligamentum venosum posteriorly
• Right limb: Gallbladder fossa anteriorly + groove for IVC posteriorly
• Crossbar: Porta hepatis - the gateway of the liver

---

3. Lobes of the Liver - Morphological (Gross)

Exam tip: Caudate and quadrate lobes are anatomically part of the right lobe but functionally belong to the left lobe (they receive left portal blood and drain via left hepatic duct).

---

4. Functional Segmental Anatomy - Couinaud's Segments (SURGICAL ANATOMY)

• Portal vein branch
• Hepatic artery branch
• Bile duct
• Hepatic vein drainage

"The liver is composed of 8 segments, each supplied by terminal branches of the portal vein (80% of blood flow) and hepatic artery (20%), and drained by bile ducts and hepatic veins."

• Bailey & Love's Surgery

• Left hepatic vein - between segments II/III and IV
• Middle hepatic vein - the main lobar fissure (Cantlie's line) dividing true right from left hemiliver
• Right hepatic vein - between anterior (V, VIII) and posterior (VI, VII) right sectors

Clinical pearl: Segment I (caudate) has direct venous drainage into the IVC - it is spared in Budd-Chiari syndrome because its venous drainage is independent of the hepatic veins!

---

5. Blood Supply - The Dual Supply (Most Important Concept)

Abdominal aorta
    ↓
Coeliac trunk
    ↓
Common hepatic artery
    ├── Gastroduodenal artery (descends behind duodenum)
    └── Hepatic artery proper
            ├── Right hepatic artery → cystic artery → gallbladder
            └── Left hepatic artery → left lobe

• Right hepatic artery may arise from the superior mesenteric artery (17% of cases) - "replaced right hepatic artery"
• Left hepatic artery may arise from the left gastric artery (running in lesser omentum)
• These variations are critical to know before cholecystectomy or hepatic surgery!

• Formed behind the neck of the pancreas by union of superior mesenteric vein + splenic vein
• Drains: gut (stomach to rectum), spleen, pancreas
• Carries nutrients, toxins, and bacteria from the gut → liver for first-pass metabolism
• Normal portal pressure: 5-10 mmHg (portal hypertension >12 mmHg)

Liver sinusoids
    ↓
Central veins (terminal hepatic veins)
    ↓
Three hepatic veins (Right, Middle, Left)
    ↓
Inferior Vena Cava (IVC)
    ↓
Right atrium

---

6. Porta Hepatis - The Gateway

Portal triad at porta hepatis:
- Bile duct     → RIGHT lateral
- Hepatic artery proper → LEFT lateral (medial)
- Portal vein   → POSTERIOR (largest, deepest)

---

7. Ligaments of the Liver

---

8. Microanatomy (Histology) - The Liver Lobule

• Hexagonal unit, 1-2 mm diameter
• Central vein (terminal hepatic vein) at the center
• Portal tracts at the periphery (corners of hexagon) - each contains portal vein branch + hepatic artery branch + bile duct
• Hepatocytes arranged in plates (cords) radiating from centre
• Sinusoids - specialised capillaries between hepatocyte plates
• Blood flows: portal tract → sinusoids → central vein → hepatic vein

• Based on blood supply rather than vein drainage
• Three zones based on oxygen and nutrient gradient:

---

PART 2: THE GALLBLADDER

1. Gross Anatomy

• Shape: Pear-shaped sac
• Size: 7 cm long, 3 cm wide
• Capacity: 30-50 mL (Sleisenger)
• Position: In the gallbladder fossa on the visceral (inferior) surface of the liver, between the right and quadrate lobes
• Function: Stores, concentrates (5-10x), and releases bile

Clinical pearl: Gallstones can impact in Hartmann's pouch, obstructing the cystic duct and causing cholecystitis. If inflammation spreads to compress the adjacent common hepatic duct, this causes Mirizzi syndrome (obstructive jaundice).

---

2. Biliary System - The Complete Ductal Tree

Right and Left hepatic ducts (emerge from liver at porta hepatis)
              ↓
    Common Hepatic Duct (CHD)
              ↓
    + Cystic Duct (from gallbladder neck, ~4 cm long)
              ↓
    Common Bile Duct (CBD) (~8 cm long, 6-8 mm diameter)
              ↓
    Joined by Main Pancreatic Duct (of Wirsung)
              ↓
    Ampulla of Vater → opens into 2nd part of duodenum
    (Sphincter of Oddi controls flow)

• Runs in the free edge of lesser omentum (hepatoduodenal ligament) - right side
• Passes behind the 1st part of duodenum
• Runs in a groove on the posterior surface of the pancreatic head
• Carcinoma of head of pancreas compresses the CBD here → painless obstructive jaundice (Courvoisier's law)

---

3. Blood, Lymph, and Nerve Supply of the Gallbladder

• Cystic artery - usually a branch of the right hepatic artery
• Divides near the gallbladder neck into superficial (serosal) and deep (intramural) branches
• Cystic artery is an end artery → ischaemic necrosis occurs easily in severe cholecystitis!
• Arterial variations are common and critically important in laparoscopic cholecystectomy

• Cystic vein → portal vein (or directly into hepatic sinusoids)
• Some small veins drain directly into the liver from the gallbladder bed

• Lymph nodes at the neck of the gallbladder (Lund's node / Calot's node)
• → Coeliac nodes → cisterna chyli

• Sympathetic: Coeliac axis (T7-T9) - travels with hepatic artery and portal vein
• Parasympathetic: Vagus nerve - regulates gallbladder motility (contraction in response to CCK)
• Visceral pain from gallbladder → referred to right subcostal, epigastric, and right scapular (shoulder tip) regions via sympathetic fibres

---

4. Triangle of Calot (Hepatocystic Triangle) - SURGICAL LANDMARK

Triangle of Calot boundaries:
- Superior border:  Inferior surface of the liver (right lobe)
- Medial border:    Common hepatic duct
- Lateral border:   Cystic duct

Contents:
- Cystic artery (must be identified and ligated)
- Cystic lymph node (node of Calot/Lund)

Exam tip: Before clipping and dividing, surgeons must achieve the "critical view of safety" - identifying only 2 structures entering the gallbladder (cystic duct and cystic artery) in the cleared triangle. Failure to do so is the most common cause of bile duct injury during cholecystectomy.

---

5. Wall Structure of the Gallbladder

1. Mucosa - columnar epithelium with folds (rugae) that allow expansion; no muscularis mucosa
2. Lamina propria
3. Tunica muscularis - smooth muscle (longitudinal + spiral)
4. Perimuscular connective tissue
5. Serosa (on free surface) / Adventitia fused with liver capsule (on hepatic surface)

---

Quick Summary Tables

Liver at a Glance

Gallbladder at a Glance

---

---

Laparoscopic Cholecystectomy (Lap Chole) - Step-by-Step for MBBS Intern

---

Background - Why Lap Chole?

• Smaller incisions (4 small ports vs. one large cut)
• Less postoperative pain
• Shorter hospital stay (often same-day or next morning)
• Faster return to normal activity
• Better cosmesis
• Mortality: 0.1-0.5%, Morbidity: 2-3% (Sabiston)

---

Indications

• Symptomatic cholelithiasis (biliary colic)
• Acute cholecystitis (gold standard even in the acute setting)
• Chronic cholecystitis
• Gallstone pancreatitis (after resolution)
• Empyema / mucocele of gallbladder
• Porcelain gallbladder (risk of malignancy)
• Gallbladder polyps >10 mm

Contraindications

---

The Operation - Step by Step

STEP 1: Anaesthesia and Preparation

• General anaesthesia with muscle relaxation is mandatory (the only way to tolerate pneumoperitoneum)
• Patient positioned supine on the operating table
• One arm tucked (to allow intraoperative cholangiogram if needed)
• Orogastric tube placed to decompress stomach (improves view of upper abdomen)
• Foley catheter if prolonged operation expected
• Abdomen prepped and draped widely - must accommodate open surgery conversion if needed
• Patient secured well to table (for steep positioning changes)

---

STEP 2: OR Setup and Patient Positioning

• Surgeon stands to the left of the patient (American technique) or between patient's legs (French technique)
• Two video monitors, one on each side of the table
• After pneumoperitoneum: patient tilted to reverse Trendelenburg 30° + 15° left rotation
• This causes colon and duodenum to fall away from the liver by gravity - crucial for exposure

---

STEP 3: Establishing Pneumoperitoneum

• Non-combustible (safe with electrocautery)
• Rapidly absorbed from peritoneal cavity
• Soluble in blood

⚠️ Caution: CO₂ causes hypercarbia in patients with significant cardiopulmonary disease. Anaesthetist monitors CO₂ levels throughout.

---

STEP 4: Port (Trocar) Placement - The Standard 4-Port Technique

---

STEP 5: Retraction and Exposure

1. Fundus grasped and pushed cephalad (upward toward right shoulder) by the assistant via Port 4 - this rolls the liver up and out of the way
2. Infundibulum (neck/Hartmann's pouch) grasped and retracted inferolaterally (downward and to the right) by the surgeon via Port 3 - this stretches open the Triangle of Calot and pulls the cystic duct AWAY from the CBD (critical for safety)

"A key maneuver is for the surgeon's left operative instrument to distract the infundibulum/Hartmann pouch laterally."

• Sabiston Textbook of Surgery

---

STEP 6: Dissection of the Hepatocystic Triangle (Triangle of Calot)

• Superior: under-surface of the liver
• Medial: common hepatic duct
• Lateral: cystic duct

1. The peritoneum on BOTH anterior AND posterior aspects of the hepatocystic triangle is incised
2. Dissection begins on the gallbladder side (known structure) and proceeds distally - never start blindly in an unknown area
3. Use fine-tipped dissecting forceps (Maryland dissector) to sweep fibroareolar tissue off the infundibulum
4. The dissection starts 4-5 cm proximal to the neck of the gallbladder (modified top-down technique)
5. Keep dissecting until the lower third of the gallbladder is separated from the liver bed - so you can see liver substance (cystic plate) through the window
6. The Calot's node (lymph node) is a useful landmark - it almost always sits directly on top of the cystic artery

---

STEP 7: Achieving the Critical View of Safety (CVS)

This is the MOST IMPORTANT safety step in the entire operation. Do NOT clip or cut anything until this is confirmed.

1. The hepatocystic triangle is completely cleared of fat and fibrous tissue
2. Only TWO structures are seen entering the gallbladder (cystic duct + cystic artery) - nothing else
3. The lower third of the gallbladder is separated from the liver bed (cystic plate visible)

"There should be two, and only two, structures (the cystic duct and artery) crossing this window - this is the 'critical view of safety,' which should be demonstrated prior to clipping or cutting any tubular structures."

• Maingot's Abdominal Operations

---

STEP 8: Intraoperative Cholangiogram (Selective Use)

• Anatomy is unclear or abnormal
• Suspected CBD stones (gallstone pancreatitis, dilated CBD on USS)
• Abnormal LFTs
• Unclear biliary anatomy during dissection

---

STEP 9: Clipping and Dividing the Cystic Structures

Cystic ARTERY first:
  - 2 clips on the patient side (liver side)
  - 1 clip on the gallbladder side
  - Divided between clips with scissors

Cystic DUCT second:
  - 2 clips on the patient side (CBD side)
  - 1 clip on the gallbladder side
  - Divided between clips with scissors

• Never clip anything until CVS is confirmed
• Always place clips at right angles to the duct
• Leave adequate length of cystic duct stump (too short → CBD risk; too long → stump chole)
• Inspect clips before and after division

---

STEP 10: Dissection of Gallbladder from Liver Bed

• Electrocautery (hook cautery) is used to dissect the gallbladder off its hepatic fossa
• Plane: just below the gallbladder serosa, superficial to the liver parenchyma
• Small venules drain directly from the gallbladder into the liver bed → excellent haemostasis needed
• Kept attached by the fundus until complete - the superior traction of the fundus at this stage gives excellent exposure back to the Triangle of Calot for one final check of the clips

"The cystic duct and cystic artery clips are inspected just before completion of the dissection of the fundic attachments because the superior traction of the fundus has provided exposure to the porta and triangle of Calot."

• Sabiston

---

STEP 11: Specimen Extraction

• Gallbladder is placed in a retrieval bag (reduces port-site wound contamination)
• Bag brought out through the umbilical (12 mm) port
• If the gallbladder is large or contains big stones: the umbilical fascial incision may need to be slightly extended to allow extraction
• If bile spills during extraction: irrigate thoroughly and retrieve all stones - spilled stones can cause late subhepatic abscesses, fistulae, or empyemas years later

---

STEP 12: Final Inspection, Irrigation, and Port Closure

• Inspect the liver bed for haemostasis and bile leak (watch for 2-3 minutes)
• Inspect the gallbladder clips once more - confirm they are secure
• Irrigate if any soiling occurred
• Deflate CO₂ (full deflation reduces shoulder-tip pain from diaphragmatic irritation)
• Close port sites:
  • 12 mm umbilical port: Fascial closure mandatory (risk of port-site hernia)
  • 5 mm ports: Skin closure only (fascia does not routinely require closure)
• Subcuticular or interrupted skin sutures at each port site

---

Conversion to Open Surgery

• Inability to achieve CVS
• Dense adhesions obscuring anatomy
• Uncontrolled bleeding
• Bile duct injury identified intraoperatively
• Bile duct obstruction/malignancy found
• Equipment failure

"Laparoscopic cholecystectomy for acute cholecystitis may carry longer operative times and a higher conversion rate to the open procedure."

• Sabiston

---

Complications

---

Key Takeaways for an Intern

Lap Chole in 12 Steps:
1.  GA + patient prep (supine, arm tucked)
2.  OR setup (reverse Trendelenburg + left tilt after insufflation)
3.  Pneumoperitoneum (Veress needle or Hasson open) with CO₂ at 12-15 mmHg
4.  4 ports (12mm umbilical, 5mm subxiphoid, 5mm midclavicular, 5mm axillary)
5.  Retract: fundus UP + infundibulum DOWN and LATERAL
6.  Lyse adhesions
7.  Dissect hepatocystic triangle (both anterior & posterior peritoneum)
8.  Achieve CRITICAL VIEW OF SAFETY (most important step!)
9.  Cholangiogram if needed
10. Clip + divide cystic ARTERY then cystic DUCT (2+1 clips)
11. Hook cautery to dissect gallbladder from liver bed
12. Bag + extract via umbilical port → inspect → irrigate → close fascia at 12mm port

The cardinal rule: Never clip until Critical View of Safety is confirmed.
The commonest serious complication: CBD injury from misidentification.

---

---

Courvoisier's Law - Simple Explanation for Interns

---

The Law - One Sentence

"In a jaundiced patient, a palpable, non-tender gallbladder is unlikely to be due to gallstones - it usually means malignant obstruction."

---

The Diagram (This is All You Need to Remember)

---

The Logic - WHY Does This Happen?

Scenario 1: Gallstone obstructing the CBD

• Gallstones don't appear suddenly. They form in the gallbladder over years
• During that time, repeated bouts of cholecystitis and inflammation damage the gallbladder wall
• The wall becomes fibrosed, scarred, and thickened - it loses its ability to stretch
• So when a stone finally slips into the CBD and blocks it, the gallbladder cannot distend - it is already stiff from chronic scarring
• Result: gallbladder NOT palpable

Scenario 2: Malignant obstruction (e.g., carcinoma head of pancreas)

• The tumour grows slowly and silently compresses the CBD from outside
• The gallbladder itself has never been inflamed - its wall is normal and healthy
• A healthy gallbladder wall is thin and elastic, like a balloon
• Bile backs up behind the obstruction → gallbladder fills up and distends massively
• Result: gallbladder palpable and non-tender (no inflammation)

"When the common duct is obstructed by a stone, distension of the gallbladder (which is likely to be chronically inflamed) is rare; when the duct is obstructed in some other way, such as a neoplasm, distension of the normal gallbladder is common."

• Bailey & Love's Surgery 28E

---

Summary Table

---

Causes of a Courvoisier Gallbladder (Palpable + Non-Tender in Jaundice)

1. Carcinoma of the head of pancreas - most common cause
2. Carcinoma of the ampulla of Vater (ampullary carcinoma)
3. Cholangiocarcinoma (distal bile duct)
4. Duodenal carcinoma
5. Mirizzi syndrome (rarely - stone impacted in cystic duct compressing CBD)

"Deep jaundice without pain, particularly with a palpable gallbladder (Courvoisier sign), suggests neoplastic obstruction of the bile duct, even when the patient has stones in the gallbladder."

• Sleisenger & Fordtran's Gastrointestinal and Liver Disease

---

What Investigations Follow?

1. Ultrasound abdomen - dilated CBD? Liver metastases? Pancreatic mass?
2. Contrast-enhanced CT abdomen - defines the tumour, checks resectability (involvement of SMA, portal vein, coeliac axis)
3. MRI/MRCP - maps biliary tree, shows level of obstruction
4. ERCP - if diagnostic doubt, cholangitis, or deep jaundice needing stenting (also gets brush cytology/biopsy)
5. Tumour markers - CA 19-9 (pancreatic ca), CEA
6. LFTs, coagulation - obstructive pattern (↑ALP, ↑bilirubin, prolonged PT from vitamin K malabsorption)

---

Important Caveat (Exam Trap!)

• A jaundiced patient with gallstones can still have a palpable gallbladder if there is no prior cholecystitis (first-time obstruction, no scarring yet)
• Conversely, a malignant obstruction may not produce a palpable gallbladder if the tumour is too proximal (above the cystic duct insertion)

The law tells you what is unlikely, not what is impossible.

---

One-Line Exam Answer

Courvoisier's Law: "In obstructive jaundice, a palpable non-tender gallbladder is unlikely due to stones - because stone disease causes chronic cholecystitis and fibrosis preventing distension. It usually indicates periampullary malignancy, most often carcinoma of the head of the pancreas."

---

---

Bile Leak - How Much is Significant?

---

The Short Answer

1. Biochemical definition - drain fluid bilirubin vs serum bilirubin ratio
2. Output volume per day - low vs high output
3. Clinical impact - does the patient need more than just a drain?

---

1. The ISGLS Definition (Gold Standard)

A bile leak is defined as: Drain fluid with a bilirubin concentration at least 3 times the concurrent serum bilirubin, measured on or after postoperative day 3

The need for radiological intervention (percutaneous drainage of a biloma) or relaparotomy for bile peritonitis - even without a surgical drain in place

---

2. ISGLS Grading - Grade A, B, C

Grade A alone = not dangerous. Grade B and C = clinically significant.

---

3. Volume Thresholds - The Practical Numbers

"If the output is low, it can be managed with drainage alone as these are usually from the cystic duct stump or a small accessory duct of Luschka and will likely close on their own. If the patient is hemodynamically unstable or there is high output from the drain (>200 mL/24 hours), then the best modality for diagnosis and therapy is an ERCP with sphincterotomy/stenting."

• Fischer's Mastery of Surgery 8E

---

4. Sources of Bile Leak - Why It Matters

---

5. Warning Signs That Make a Leak Immediately Dangerous

• Bile peritonitis - bile irritates the peritoneum severely; causes chemical peritonitis with intense pain, rigidity, fever
• Haemodynamic instability - sepsis from infected biloma/peritonitis
• Rising bilirubin - undrained bile leaking into the cavity
• Failure to improve with conservative management after 48-72 hours
• Biloma enlarging on serial imaging

"If peritonitis is present or develops during management of the leak, then drainage is inadequate and reoperation may be required."

• Fischer's Mastery of Surgery 8E

---

6. Amsterdam Classification (Post-Cholecystectomy Leaks Specifically)

---

Quick Summary for the Intern

Bile Leak = Dangerous When:

BIOCHEMICAL DEFINITION (ISGLS):
  Drain bilirubin ≥ 3× serum bilirubin ON or AFTER Day 3

VOLUME THRESHOLD:
  Low output  < 200-300 mL/day  → Conservative (drain alone, may close)
  High output > 200-300 mL/day  → ERCP + stent needed urgently

GRADE (ISGLS):
  Grade A → Drain-controlled, patient well → Not dangerous
  Grade B → Needs ERCP/PTCD/antibiotics → Significant
  Grade C → Needs relaparotomy → Life-threatening

RED FLAGS (act immediately regardless of volume):
  ✗ Bile peritonitis (pain, rigidity, fever)
  ✗ Haemodynamic instability / sepsis
  ✗ Enlarging biloma on imaging
  ✗ Rising serum bilirubin
  ✗ Not improving after 48-72h of drainage

---